{
  "docId": "019de070-a24a-718d-8fa7-de49d427834d",
  "docSlug": "119c472f2b470327a8fb07de55a72f86",
  "documentTitle": "Alkermes | Results Presentation Deck | 15 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 12,
  "pageCount": 15,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 8,
  "notes": "The chart includes a vertical dashed line between Q4'19 and Q1'20, likely indicating a fiscal or calendar year transition.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-a24a-718d-8fa7-de49d427834d/12",
  "deckHref": "/decks/019de070-a24a-718d-8fa7-de49d427834d",
  "deckJsonHref": "/decks/019de070-a24a-718d-8fa7-de49d427834d.json",
  "deckAnchorHref": "/decks/019de070-a24a-718d-8fa7-de49d427834d#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.61,
        "x": 0.043,
        "y": 0.255
      },
      "kind": "chart",
      "text": "ARISTADA Quarterly TRx MOT",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1d4ead56-f1a2-49b1-8d21-8e960558e211",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.28,
        "x": 0.675,
        "y": 0.26
      },
      "kind": "list",
      "text": "Q4 year-over-year growth of 16% on TRx months of therapy (MOT) basis; Outpaced overall atypical long-acting injectable (LAI) market Q4 year-over-year growth of 5%. Market share: TRx MOT: 9.1% of atypical LAI market prescriptions in Q4 '20",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "187123f0-5315-49db-bfaf-3aa412d77081",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.08,
        "x": 0.05,
        "y": 0.86
      },
      "kind": "source-note",
      "text": "Source: IQVIA NPA",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "21c358bb-4160-4cb4-8443-d7790239b007",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.365,
        "x": 0.037,
        "y": 0.095
      },
      "kind": "title",
      "text": "ARISTADA®: Prescription Growth Trends",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4f514743-6fab-4d2b-bcf5-4530db8ad77c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 12,
      "from": 10,
      "beatId": "a394fcba-6d0b-4d60-a7d0-94a71917b20f",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Product Performance",
      "beatSlug": "sequoia-pitch-product",
      "evidence": "The presentation highlights the performance of Alkermes' products, VIVITROL and ARISTADA",
      "position": 2,
      "confidence": 0.7,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 12,
      "from": 10,
      "name": "Voice Of Customer",
      "slug": "51-voice-of-customer",
      "bestFor": "Product strategy, customer experience, market research",
      "matchId": "8be22c2a-fe37-44db-9fe1-e06dca17934f",
      "evidence": "The presentation provides data on VIVITROL and ARISTADA performance",
      "position": 1,
      "objective": "Provide insights into product performance and expectations",
      "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response",
      "confidence": 0.6,
      "description": "Let customer quotes and feedback drive the narrative and validate the insight"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}